Bilateral breast adenocarcinomas with EML4—ALK fusion in a patient with multiple metastases successfully treated with crizotinib: is lung the primary site?

Bilateral breast adenocarcinomas with EML4—ALK fusion in a patient with multiple metastases successfully treated with crizotinib: is lung the primary site?

Chao Liu,1,2 Lijuan Ding,2 Bing Sun,2 Shikai Wu1,2 1Department of Radiation Oncology, 307 Hospital of People’s Liberation Army, 307 Clinical College, Anhui Medical University, 2Department of Radiation Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, People&a...

Full description

Bibliographic Details
Main Authors: Liu C, Ding L, Sun B, Wu S
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:OncoTargets and Therapy
Subjects:
crizotinib
anaplastic lymphoma kinase inhibitor
metastatic adenocarcinoma
gene expression profiling
Online Access:https://www.dovepress.com/bilateral-breast-adenocarcinomas-with-eml4mdashalk-fusion-in-a-patient-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/bilateral-breast-adenocarcinomas-with-eml4mdashalk-fusion-in-a-patient-peer-reviewed-article-OTT

Similar Items